Chondroitin sulfate prevents platelet derived growth factor-mediated phosphorylation of PDGF-Rβ in normal human fibroblasts severely impairing mitogenic responses

Journal of Cellular Biochemistry

Volumn 103, Issue 6, 2008, Pages 1866-1876

  Fthenou, E ^a   Zafiropoulos, A ^a   Katonis, P ^a   Tsatsakis, A ^a   Karamanos, N K ^b   Tzanakakis, G N ^a,c  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Chondroitin sulfate; Fibroblasts; PDGF BB; PDGFR

Indexed keywords

BETA XYLOSIDE; CHONDROITIN SULFATE; MONOSACCHARIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; CHONDROITIN SULFATES; FIBROBLASTS; GLYCOSIDES; HUMANS; LUNG; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 41849098913     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21570     Document Type: Article

References (32)

1. Andersson M, Ostman A, Westermark B, Heldin CH. 1994. Characterization of the retention motif in the C-terminal part of the long splice form of platelet-derived growth factor A-chain. J Biol Chem 269:926-930.
2. Cartel NJ, Post M. 2005. Abrogation of apoptosis through PDGF-BB-induced sulfated glycosaminoglycan synthesis and secretion. Am J Physiol Lung Cell Mol Physiol 288:L285-L293.
3. de La Motte CA, Hascall VC, Calabro A, Yen-Lieberman B, Strong SA. 1999. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J Biol Chem 274:30747-30755.
4. Denholm EM, Cauchon E, Poulin C, Silver PJ. 2000. Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate. Eur J Pharmacol 400:145-153.
5. Fager G, Camejo G, Olsson U, Ostergren-Lunden G, Lustig F, Bondjers G. 1995. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells. J Cell Physiol 163:380-392.
6. Ferrao AV, Mason RM. 1993. The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts. Biochim Biophys Acta 1180:225-230.
7. Fthenou E, Zafiropoulos A, Tsatsakis A, Stathopoulos A, Karamanos NK, Tzanakakis GN. 2006. Chondroitin sulfate A chains enhance platelet derived growth factor-mediated signalling in fibrosarcoma cells. Int J Biochem Cell Biol 38:2141-2150.
8. Garcia-Olivas R, Hoebeke J, Castel S, Reina M, Fager G, Lustig F, Vilaro S. 2003. Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans. Histochem Cell Biol 120:371-382.
9. Kelly JD, Raines EW, Ross R, Murray MJ. 1985. The B chain of PDGF alone is sufficient for mitogenesis. EMBO J 4:3399-3405.
10. Lesley J, Hascall VC, Tammi M, Hyman R. 2000. Hyaluronan binding by cell surface CD44. J Biol Chem 275:26967-26975.
11. Li L, Heldin CH, Heldin P. 2006. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J Biol Chem 281:26512-26519.
12. Lugemwa FN, Esko JD. 1991. Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis. J Biol Chem 266:6674-6677.
13. Lustig F, Hoebeke J, Ostergren-Lunden G, Velge-Roussel F, Bondjers G, Olsson U, Ruetschi U, Fager G. 1996. Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans. Biochemistry 35:12077-12085.
14. Lustig F, Hoebeke J, Simonson C, Ostergren-Lunden G, Bondjers G, Ruetchi U, Fager G. 1999. Processing of PDGF gene products determines interactions with glycosaminoglycans. J Mol Recognit 12:112-120.
15. Lyon M, Rushton G, Gallagher JT. 1997. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J Biol Chem 272:18000-18006.
16. Maeda N, Nishiwaki T, Shintani T, Hamanaka H, Noda M. 1996. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J Biol Chem 271:21446-21452.
17. Miao HQ, Fritz TA, Esko JD, Zimmermann J, Yayon A, Vlodavsky I. 1995. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor. J Cell Biochem 57:173-184.
18. Milev P, Monnerie H, Popp S, Margolis RK, Margolis RU. 1998. The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity. J Biol Chem 273:21439-21442.
19. Nikitovic D, Zafiropoulos A, Tzanakakis GN, Karamanos NK, Tsatsakis AM. 2005. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions. Anticancer Res 25:2851-2856.
20. Nili N, Cheema AN, Giordano FJ, Barolet AW, Babaei S, Hickey R, Eskandarian MR, Smeets M, Butany J, Pasterkamp G, Strauss BH. 2003. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: Potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am J Pathol 163:869-878.
21. Pollock RA, Richardson WD. 1992. The alternative-splice isoforms of the PDGF A-chain differ in their ability to associate with the extracellular matrix and to bind heparin in vitro. Growth Factors 7:267-277.
22. Rapraeger A, Yeaman C. 1989. A quantitative solid-phase assay for identifying radiolabeled glycosaminoglycans in crude cell extracts. Anal Biochem 179:361-365.
23. Rapraeger A, Krufka A, Olwin BB. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708.
24. Ronnstrand L, Heldin CH. 2001. Mechanisms of platelet-derived growth factor-induced Chemotaxis. Int J Cancer 91:757-762.
25. Schneller M, Vuori K, Ruoslahti E. 1997. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J 16:5600-5607.
26. Selbi W, de la Motte CA, Hascall VC, Day AJ, Bowen T, Phillips AO. 2006. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int 70:1287-1295.
27. Syrokou A, Tzanakakis G, Tsegenidis T, Hjerpe A, Karamanos NK. 1999a. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: A structure-function relationship. Cell Prolif 32:85-99.
28. Syrokou A, Tzanakakis GN, Hjerpe A, Karamanos NK. 1999b. Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity. Biochimie 81: 733-744.
29. Tallquist M, Kazlauskas A. 2004. PDGF signaling in cells and mice. Cytokine Growth Factor Rev 15:205-213.
30. Tingstrom A, Reuterdahl C, Lindahl P, Heldin CH, Rubin K. 1992. Expression of platelet-derived growth factor-beta receptors on human fibroblasts. Regulation by recombinant platelet-derived growth factor-BB, IL-1, and tumor necrosis factor-alpha. J Immunol 148:546-554.
31. Westergren-Thorsson G, Persson S, Isaksson A, Onnervik PO, Malmstrom A, Fransson LA. 1993. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp Cell Res 206:93-99.
32. Woodard AS, Garcia-Cardena G, Leong M, Madri JA, Sessa WC, Languino LR. 1998. The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J Cell Sci 111(Pt 4):469-478.